By Bachem AG
To get in touch with Bachem AG, simply fill out the form below.
Subscribe to Supplier
Bachem is Bronze Sponsor for Europe’s premier meeting for biologics R&D
Bubendorf, Switzerland: –Peptide technology specialist Bachem AG will present innovative approaches to mass spectrometry (MS) characterization of modified synthetic RNA to Europe’s premier conference for biologics research in late March.
Bachem is a Bronze Sponsor of the upcoming Biologics UK Conference and will also be an exhibitor at the event from Booth 27 at the Novotel West London.
Novel approaches to RNA characterization
The Bachem team at the In Person event will include Quality Control Project Chemist Dr. Giovanni Calderis, who will deliver a presentation on ‘Novel Approaches In MS Characterization of Highly Modified Synthetic RNA’.
Peptides Business Development Manager Zina Zokouri and Peptides and Oligonucleotides Business Development Manager Seamus White will also represent Bachem at the conference and exhibition. An interview with Mr. White features in a recently posted video that focuses on Bachem’s expansion into oligo development and manufacturing (see Resources).
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.
About Biologics UK 2022
The annual Biologics UK conference bills itself as Europe’s Premier Meeting for Biologics R&D.
The conference provides an international scientific audience with opportunities to share latest research and innovations, advance biologics research through immersive, discussion-based sessions within a committed community and engage with peers in a dynamic networking environment.
The Biologics UK In Person 2022 is a two-day face-to-face event open March 21 at the Novotel West in Hammersmith, West London, followed by a Digital Day for online sessions on March 23.
The conference includes tracks on Proteins, Antibodies & Bispecifics including presentations on protein & antibody engineering, bioanalysis, bispecific antibodies & cell engagers, as well as Peptides & Oligonucleotides, including case studies examining the latest challenges and innovations in early peptide and oligonucleotides drug development including synthesis technologies.
The event is organized by Oxford Global as part of its international Biologics Series. Further information at: https://www.oxfordglobal.co.uk/biologics-series/
Click on Oligonucleotides – Innovation that transforms lives to watch video.
Click on Expanding into Oligos – Interview with Seamus White to watch video.
Click on Bachem Oligonucleotide New Chemical Entities NCEs for more information.
Subscribe to Bachems Newsletter to receive the latest updates.